KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other financing activities (2019 - 2025)

Historic Other financing activities for ClearPoint Neuro (CLPT) over the last 7 years, with Q3 2025 value amounting to $2.0 million.

  • ClearPoint Neuro's Other financing activities rose 619.75% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 4496.42%. This contributed to the annual value of $6.9 million for FY2024, which is 1362.07% up from last year.
  • ClearPoint Neuro's Other financing activities amounted to $2.0 million in Q3 2025, which was up 619.75% from $2.3 million recorded in Q2 2025.
  • ClearPoint Neuro's 5-year Other financing activities high stood at $2.3 million for Q2 2025, and its period low was $247000.0 during Q2 2021.
  • In the last 3 years, ClearPoint Neuro's Other financing activities had a median value of $1.8 million in 2024 and averaged $1.5 million.
  • Within the past 5 years, the most significant YoY rise in ClearPoint Neuro's Other financing activities was 4035.09% (2021), while the steepest drop was 248.96% (2021).
  • ClearPoint Neuro's Other financing activities (Quarter) stood at $247000.0 in 2021, then soared by 589.47% to $1.7 million in 2024, then grew by 18.73% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.3 million for Q2 2025, and $1.9 million during Q1 2025.